News
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Apr 24
Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
15 Apr 24
Movers
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
15 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's After-Market Session
12 Apr 24
Movers
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
12 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
12 Apr 24
Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Apr 24
Movers
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
12 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
11 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
8 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket
5 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Allarity Therapeutics: Q4 Earnings Insights
8 Mar 24
Earnings
Allarity Therapeutics FY Net loss Of $(11.9)M Compared To $(16.1)M YoY
8 Mar 24
Earnings, News
Press releases
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
17 Apr 24
Press Releases
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
4 Apr 24
Press Releases
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
27 Mar 24
Biotech, Press Releases, General
Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1)
25 Mar 24
Press Releases
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
8 Mar 24
Press Releases
Allarity Therapeutics to Present at Biomarkers 2024
28 Feb 24
Press Releases